Understanding and treating cell death in type 1 diabetes
Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes
This study is looking at how a special pathway in our cells might help protect insulin-producing cells from damage in type 1 diabetes, using a compound called BRD0476, with the hope of finding new ways to keep these important cells healthy and improve treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10843849 on NIH RePORTER |
What this research studies
This research investigates how the ubiquitin pathway affects the death of insulin-producing beta cells in type 1 diabetes. By using a compound called BRD0476, the study aims to understand how this compound can protect beta cells from damage caused by immune responses. The researchers are exploring the cellular mechanisms involved in beta-cell loss and how manipulating these pathways could lead to new treatments. Patients may benefit from insights that could help identify those at risk and develop therapies to preserve beta-cell function.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 1 diabetes, particularly those in the early stages of the disease.
Not a fit: Patients with type 2 diabetes or those who do not have any form of diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that protect insulin-producing cells and improve outcomes for individuals with type 1 diabetes.
How similar studies have performed: Other research has shown promise in targeting cellular pathways to protect beta cells, suggesting that this approach could lead to meaningful advancements in treatment.
Where this research is happening
Cambridge, United States
- Broad Institute, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Choudhary, Amit — Broad Institute, INC.
- Study coordinator: Choudhary, Amit
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.